Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Phillip Gorelick

Vascular Neurology Chicago, IL Medical Doctor

NPI 1902841273 CMS profile 131237

259 E Erie St, Chicago, IL 60611

Open in the dashboard

General payments

$268,899

245 records reported · program years 2019–2025

Research payments

$58,683

Paid to them · 39 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$46,488 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Phillip Gorelick of Chicago, IL is reported in the CMS Open Payments database as having received $268,899 across 245 general payments and $58,683 in research payments paid to them. Separately, studies naming them as principal investigator received $46,488 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Vascular Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

14 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $12,416 24
2025 Research $14,950 6
2024 General $38,904 34
2024 Research $22,705 14
2023 General $22,937 27
2023 Research $4,705 3
2022 General $57,680 46
2022 Research $3,288 7
2021 General $93,583 72
2021 Research $8,119 5
2020 General $14,619 17
2020 Research $4,088 2
2019 General $28,761 25
2019 Research $827 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Phillip Gorelick
  • Vascular Neurology median
  • Middle half of Vascular Neurology
  • National median

In program year 2025, general payments to Phillip Gorelick were reported at $12,416. Among 416 Vascular Neurology profiles paid that year, the median was $360 and the middle half received between $91 and $1,472.

Show as a table
Year Phillip Gorelick Vascular Neurology median Middle half National median
2019 $28,761 $263 $102–$1,640 $163
2020 $14,619 $153 $45–$1,000 $114
2021 $93,583 $261 $100–$1,355 $132
2022 $57,680 $242 $87–$1,273 $149
2023 $22,937 $322 $97–$1,266 $160
2024 $38,904 $247 $70–$1,053 $164
2025 $12,416 $360 $91–$1,472 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AstraZeneca Pharmaceuticals LP $62,817 56 payments
  2. Ucb SA $35,790 44 payments
  3. E.R. Squibb & Sons, L.L.C. $31,427 21 payments
  4. Amgen Inc. $26,125 12 payments
  5. AstraZeneca UK Limited $23,136 40 payments
  6. RedHill Biopharma Inc. $22,892 5 payments
  7. UCB Biosciences Inc. $22,270 24 payments
  8. AbbVie, Inc. $17,123 8 payments
  9. UCB GmBH $5,910 6 payments
  10. Sanofi-Aventis U.S. LLC $5,534 13 payments
  11. Other $15,877 16 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $268,812 242 payments
  2. Food and Beverage $87 3 payments
Products named General payments · program years 2019–2025
  1. SOTYKTU $30,777 20 payments
  2. AIMOVIG $26,125 12 payments
  3. Movantik Opioid Antagonist $22,892 5 payments
  4. SAPHNELO $15,097 24 payments
  5. TEZSPIRE $14,438 18 payments
  6. Bimzelx $6,790 18 payments
  7. MOVANTIK Neuroscience $5,027 2 payments
  8. BREZTRI $4,640 11 payments
  9. INVOKANA $3,800 2 payments
  10. UBRELVY $2,200 1 payment
  11. Other $1,262 5 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Bausch Health US, LLC $32,216 18 payments
  2. E.R. Squibb & Sons, L.L.C. $11,700 10 payments
  3. Novartis Pharma AG $9,440 6 payments
  4. Amgen Inc. $3,250 1 payment
  5. Shockwave Medical, Inc $1,250 2 payments
  6. AstraZeneca UK Limited $827 2 payments

Records

284 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Neurology in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record